Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide
Crossref DOI link: https://doi.org/10.1007/s11060-015-1717-1
Published Online: 2015-01-13
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goldwirt, Lauriane
Beccaria, Kevin
Carpentier, Alexandre
Idbaih, Ahmed
Schmitt, Charlotte
Levasseur, Camille
Labussiere, Marianne
Milane, Aline
Farinotti, Robert
Fernandez, Christine
Text and Data Mining valid from 2015-01-13